Editorial Advisory Board Member, Harvard Health Publishing The GLP-1 drugs, which include semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro, Zepbound), are turning out to have effects that go beyond shedding pounds and controlling diabetes
Checked for purity, heavy metals, and pesticides before leaving our facility
For many patients, this translates into feeling full sooner, thinking about food less often, and having more control over portion sizes
Reduced body mass often improves blood pressure, potentially causing over-medication
*You are not obligated to fill your RX with our pharmacy
It is also possible that some of the effects of GLP-1 agonists on food intake may be mediated by interaction with sensory afferent neurones of the vagus nerves in the gastrointestinal tract